发明名称 Phthalazinone derivatives
摘要 <p>Compounds of the formula (I): wherein A and B together represent an optionally substituted, fused aromatic ring; X can be NR<X> or CR<X>R<Y>; if X NR<X> then n is 1 or 2 and if X = CR<X>R<Y> then n is 1; R<X> is selected from the group consisting of H, optionally substituted C1-20 alkyl, C5-20 aryl, C3-20 heterocyclyl, amido, thioamido, ester, acyl, and sulfonyl groups; R<Y> is selected from H, hydroxy, amino; or R<X> and R<Y> may together form a spiro-C3-7 cycloalkyl or heterocyclyl group; R<C1> and R<C2> are both hydrogen, or when X is CR<X> R<Y>, R<C1>, R<C2>, R<X> and R<Y>, together with the carbon atoms to which they are attached, may form an optionally substituted fused aromatic ring; and R<1> is selected from H and halo.</p>
申请公布号 AU2004220321(A1) 申请公布日期 2004.09.23
申请号 AU20040220321 申请日期 2004.03.12
申请人 KUDOS PHARMACEUTICALS LIMITED;MAYBRIDGE LIMITED 发明人 STEPHEN PHILIP JACKSON;VINCENT M. JUNIOR LOH;XIAO-LING FAN COCKCROFT;IAN TIMOTHY WILLIAMS MATTHEWS;KEITH ALLAN MENEAR;FRANK KERRIGAN;ALAN ASHWORTH;NIALL MORRISON BARR MARTIN;GRAEME CAMERON MURRAY SMITH
分类号 A61K31/00;A61P31/20;C07D237/32;C07D401/10;C07D401/12;C07D401/14;C07D403/10;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/20;C07D491/04;C07D495/04;(IPC1-7):C07D237/32;A61K31/502;C07D407/12 主分类号 A61K31/00
代理机构 代理人
主权项
地址